430 related articles for article (PubMed ID: 23429938)
1. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer.
Sugie T; Sawada T; Tagaya N; Kinoshita T; Yamagami K; Suwa H; Ikeda T; Yoshimura K; Niimi M; Shimizu A; Toi M
Ann Surg Oncol; 2013 Jul; 20(7):2213-8. PubMed ID: 23429938
[TBL] [Abstract][Full Text] [Related]
2. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
[TBL] [Abstract][Full Text] [Related]
4. Indocyanine green fluorescence mapping for sentinel lymph node biopsy in early breast cancer.
Pitsinis V; Provenzano E; Kaklamanis L; Wishart GC; Benson JR
Surg Oncol; 2015 Dec; 24(4):375-9. PubMed ID: 26555151
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
Murawa D; Hirche C; Dresel S; Hünerbein M
Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
[TBL] [Abstract][Full Text] [Related]
7. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative detection of sentinel lymph nodes in breast cancer patients using ultrasonography-guided direct indocyanine green dye-marking by real-time virtual sonography constructed with three-dimensional computed tomography-lymphography.
Yamamoto S; Maeda N; Yoshimura K; Oka M
Breast; 2013 Oct; 22(5):933-7. PubMed ID: 23726129
[TBL] [Abstract][Full Text] [Related]
10. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer.
Hojo T; Nagao T; Kikuyama M; Akashi S; Kinoshita T
Breast; 2010 Jun; 19(3):210-3. PubMed ID: 20153649
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
World J Surg Oncol; 2014 Sep; 12():290. PubMed ID: 25239029
[TBL] [Abstract][Full Text] [Related]
13. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis.
Sugie T; Ikeda T; Kawaguchi A; Shimizu A; Toi M
Int J Clin Oncol; 2017 Feb; 22(1):11-17. PubMed ID: 27864624
[TBL] [Abstract][Full Text] [Related]
15. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
16. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
[TBL] [Abstract][Full Text] [Related]
17. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer.
Wishart GC; Loh SW; Jones L; Benson JR
Eur J Surg Oncol; 2012 Aug; 38(8):651-6. PubMed ID: 22704050
[TBL] [Abstract][Full Text] [Related]
18. Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer.
Zhou Y; Li Y; Mao F; Zhang J; Zhu Q; Shen S; Lin Y; Zhang X; Liu H; Xiao M; Jiang Y; Sun Q
BMC Cancer; 2019 Oct; 19(1):939. PubMed ID: 31604469
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green detects sentinel lymph nodes in early breast cancer.
Liu J; Huang L; Wang N; Chen P
J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
[TBL] [Abstract][Full Text] [Related]
20. Predictors of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph node (Pilot study).
Eldweny H; Alkhaldy K; Alsaleh N; Abdulsamad M; Abbas A; Hamad A; Mounib S; Essam T; Kukawski P; Bobin JY; Oteifa M; Amanguono H; Abulhoda F; Usmani S; Elbasmy A
J Egypt Natl Canc Inst; 2012 Mar; 24(1):23-30. PubMed ID: 23587229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
